Kezar Life Sciences Inc (KZR) — Financial Flexibility Index
Kezar Life Sciences Inc (KZR) has a Financial Flexibility Index of -2.70x as of March 2026. Free cash flow of $-7.45 Million (operating CF $-7.45 Million minus capex $0.00) represents -3% of total liabilities ($2.76 Million). Check KZR strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kezar Life Sciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Kezar Life Sciences Inc across 10 annual periods. See how liquid is Kezar Life Sciences Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Kezar Life Sciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Kezar Life Sciences Inc. For the full company profile including market capitalisation, see KZR stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.87x | $-51.77 Million | $-51.78 Million | $6.57 Million | ▼ -194.7% |
| 2024 | -2.67x | $-74.18 Million | $-74.21 Million | $27.77 Million | ▼ -12.7% |
| 2023 | -2.37x | $-79.83 Million | $-81.64 Million | $33.66 Million | ▼ -23.0% |
| 2022 | -1.93x | $-57.27 Million | $-58.85 Million | $29.70 Million | ▲ +3.6% |
| 2021 | -2.00x | $-42.12 Million | $-42.44 Million | $21.06 Million | ▲ +40.9% |
| 2020 | -3.38x | $-36.76 Million | $-36.95 Million | $10.86 Million | ▼ -32.5% |
| 2019 | -2.55x | $-29.27 Million | $-29.88 Million | $11.47 Million | ▲ +23.6% |
| 2018 | -3.34x | $-19.67 Million | $-20.79 Million | $5.88 Million | ▼ -3360.0% |
| 2017 | -0.10x | $-7.72 Million | $-8.11 Million | $79.91 Million | ▲ +71.0% |
| 2016 | -0.33x | $-9.63 Million | $-9.76 Million | $28.85 Million | — |